Allergy Therapeutics (AGY)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

8.38p
   
  • Change Today:
      0.075p
  • 52 Week High: 8.90
  • 52 Week Low: 5.00
  • Currency: UK Pounds
  • Shares Issued: 6,141m
  • Volume: 21,800
  • Market Cap: £514.35m
  • RiskGrade: 268
  • Beta: 0.02

Latest ShareCast News

Allergy Therapeutics starts dosing peanut allergy vaccine candidate

By Josh White

Date: Monday 27 Mar 2023

(Sharecast News) - Allergy Therapeutics, a UK-based biotechnology company specialising in allergy vaccines, announced the start of the first application of its 'VLP Peanut' vaccine candidate in peanut-allergic patients on Monday.

AGY ShareCast News

Allergy Therapeutics confident in funding as res... 20-Jan-2023 ShareCast
Allergy Therapeutics pauses production at Freema... 04-Oct-2022 ShareCast
Allegy Therapeutics trades 'robustly' in tough y... 15-Jul-2022 ShareCast
Allergy Therapeutics reports positive results fr... 25-Oct-2021 ShareCast
Allergy Therapeutics upbeat on ex-vivo study of ... 03-Aug-2021 ShareCast

AGY Regulatory News

Company to Evaluate Dual Listing on HKEX 06-Nov-2025 07:22 RNS
G308 Phase III Year 2 Patient Screening Starts 30-Oct-2025 07:00 RNS
Warrant Exercise and Paydown of Debt 29-Oct-2025 07:00 RNS
Further progress in Phase I/IIa PROTECT trial 16-Oct-2025 07:00 RNS
Trading update for the year ended 30 June 2025 21-Jul-2025 07:00 RNS

AGY Newspaper Links

Allergy drug firm hit by trials setback 12-Jul-2007 The Independent
Need to Know: Global Business Briefing 25-Mar-2006 Times

AGY Tips & Analysis

FTSE Close: BP and Lloyds lead rally 21-Sep-2010 Daily Mail
Tempus:Allergy Therapeutics 22-Sep-2009 Times
Investment Column:Allergy Therapeutics 22-Sep-2009 The Independent
Market report: Wednesday lastest 14-May-2008 Daily Mail
Market Report: Prudential gains after bid specul... 13-Mar-2008 The Independent

AGY News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AGY Market Data

Currency UK Pounds
Share Price 8.38p
Change Today 0.075p
% Change 0.90 %
52 Week High 8.90
52 Week Low 5.00
Volume 21,800
Shares Issued 6,141m
Market Cap £514.35m
Beta 0.02
RiskGrade 268

AGY Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
68.95% below the market average68.95% below the market average68.95% below the market average68.95% below the market average68.95% below the market average
65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average65.85% below the sector average
Price Trend
93.47% above the market average93.47% above the market average93.47% above the market average93.47% above the market average93.47% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average
Income Not Available
Growth
53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average53.41% below the market average
79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average79.31% below the sector average

AGY Dividends

No dividends found

Trades for 06-Nov-2025

Time Volume / Share Price
11:00 6,800 @ 8.65p
11:00 1 @ 8.65p
11:00 6,799 @ 8.65p
09:00 7,000 @ 8.65p
09:00 1 @ 8.65p

AGY Key Personnel

CEO Manuel Llobet

Top of Page